Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DVAX | Common Stock | Options Exercise | $74.6K | +15K | +72% | $4.97 | 35.8K | Aug 8, 2022 | Direct | |
transaction | DVAX | Common Stock | Sale | -$258K | -15K | -41.86% | $17.17 | 20.8K | Aug 8, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DVAX | Stock Option (Right to Buy) | Options Exercise | -15K | -100% | 0 | Aug 8, 2022 | Common Stock | 15K | $4.97 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | This transaction was executed in multiple trades at prices ranging from $17.16 to $17.20; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax. |
F2 | These options fully-vested on May 30, 2020, upon the one-year anniversary of the grant date. |
F3 | Not applicable. |